Defining the role of CD2 in disease progression and overall survival among patients with completely resected stage-II to -III cutaneous melanoma-Reference-Cited by-同舟云学术

Defining the role of CD2 in disease progression and overall survival among patients with completely resected stage-II to -III cutaneous melanoma

Published:2014-06 Issue:6 Volume:70 Page:1036-1044.e3
ISSN:0190-9622
Container-title:Journal of the American Academy of Dermatology
language:en
Short-container-title:Journal of the American Academy of Dermatology

Author:

Harcharik Sara,Bernardo Sebastian,Moskalenko Marina,Pan Michael,Sivendran Meera,Bell Heather,Hall Lawrence D.,Castillo-Martín Mireia,Fox Kelly,Cordon-Cardo Carlos,Chang Rui,Sivendran Shanthi,Phelps Robert G.,Saenger Yvonne

Publisher

Elsevier BV

Subject

Dermatology

Reference29 articles.

1. Cancer treatment and survivorship statistics;Siegel;CA Cancer J Clin,2012

2. Cancer statistics, 2013;Siegel;CA Cancer J Clin,2013

3. Estimates of stage-specific survival are altered by changes in the 2002 American Joint Committee on Cancer staging system for melanoma;Ben-Porat;Cancer,2006

4. Final version of 2009 AJCC melanoma staging and classification;Balch;J Clin Oncol,2009

5. Multivariate analysis of prognostic factors among 2,313 patients with stage III melanoma: comparison of nodal micrometastases versus macrometastases;Balch;J Clin Oncol,2010

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Identification of Biomarker IL2Rβ in Ankylosing Spondylitis via Multi-Chip Integration Analysis of Gene Differential Expression;Frontiers in Bioscience-Landmark;2023-12-26

2. Targeting the epigenome in malignant melanoma: Facts, challenges and therapeutic promises;Pharmacology & Therapeutics;2022-12

3. Prognostic biomarkers of cutaneous melanoma;Photodermatology, Photoimmunology & Photomedicine;2022-01-17

4. Targeting the Epigenome in Malignant Melanoma: Facts, Challenges and Therapeutic Promises;SSRN Electronic Journal;2022

5. Bioinformatics analysis of genes associated with the patchy-type alopecia areata: CD2 may be a new therapeutic target;Biomedical Papers;2020-12-15